gut.bmj13d
ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activation
Objective Extracellular matrix protein 1 (ECM1) serves as a gatekeeper of hepatic fibrosis by maintaining transforming growth ...
gut.bmj17h
New entity of adult ultra-short coeliac disease: the first international cohort and case–control study
Background Ultra-short coeliac disease (USCD) is defined as villous atrophy only present in the duodenal bulb (D1) with concurrent positive coeliac serology. We present the first, multicentre, ...
gut.bmj19h
Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn’s disease from tuberculosis
Dr A B Pulimood, Department of Surgery, School of Surgical Sciences, Medical School, University of Newcastle, Newcastle-upon-Tyne NE2 4HH, UK. BACKGROUND Intestinal tuberculosis and Crohn’s disease ...
gut.bmj16h
Global incidence of oesophageal cancer by histological subtype in 2012
Correspondence to Dr Melina Arnold, Section of Cancer Surveillance, International Agency for Research on Cancer, 150 Cours Albert Thomas, Lyon 69008, France; arnoldm{at}fellows.iarc.fr Objective The ...
gut.bmj16h
PTU-185 What is the Cost of Duodenal Biopsies in Patients without Serological Evidence of Coeliac Disease?
Introduction The BSG guidelines recommend anti tissue transglutaminase antibody (TTG) testing as a first line test for coeliac disease. Duodenal biopsies (D2) should be performed only after a positive ...
gut.bmj14d
Leveraging the tug-of-war with genomic retroelements to enhance immunotherapy of pancreatic cancer
Correspondence to Dr Elisa Espinet; e.espinet{at}ub.edu ...
gut.bmj28d
Effects of tenofovir disoproxil fumarate on intrahepatic viral burden and liver immune microenvironment in patients with chronic hepatitis B
Background The impact of nucleos(t)ide analogues on intrahepatic viral burden and immune microenvironment in patients with chronic hepatitis B (CHB) is not clear. Objective We aimed to characterise ...
gut.bmj2d
Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B
Dr G Fattovich, Servizio Autonomo Clinicizzato di Gastroenterologia, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, Università di Verona, Via delle Menegone 10, 37134 Verona, Italy ...
gut.bmj3d
Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma
5 Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China, Shanghai, China Objective Hepatocellular carcinoma (HCC), mostly developed in fibrotic/cirrhotic liver, exhibits ...
gut.bmj5d
Alterations of gut microbiome in autoimmune hepatitis
Objective The significance of the liver-microbiome axis has been increasingly recognised as a major modulator of autoimmunity. The aim of this study was to take advantage of a large well-defined ...
gut.bmj11d
Faecal virome transplantation decreases symptoms of type 2 diabetes and obesity in a murine model
Objective Development of obesity and type 2 diabetes (T2D) are associated with gut microbiota (GM) changes. The gut viral community is predominated by bacteriophages (phages), which are viruses that ...
gut.bmj4d
Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease
Professor J P Galmiche, Centre de Recherche en Nutrition Humaine, CRI INSERM 95-08, CHU, Hôtel Dieu, Place A Ricordeau, 44035 Nantes cedex 01, France. Email:galmiche{at}easynet.fr BACKGROUND/AIM ...